|Articles|February 16, 2016
SPECIAL REPORT: GENERATION WEED
February’s Special Report focuses on the troubling trend to legalize and decriminalize recreational and medical marijuana and the risks to children and adolescents from the marketing and media hype surrounding “weed.”
Advertisement
View SPECIAL REPORT: GENERATION WEED
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
FDA approves powder formulation of trofinetide for Rett syndrome
3
FDA approves berotralstat for patients aged 2 to 11 years with hereditary angioedema
4
FDA approves Nuzolvence (zoliflodacin) for treatment of uncomplicated urogenital gonorrhea in 12 years and up
5
